The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Preimplantation Genetic Screening-Global Market Insights and Sales Trends 2024
Synopsis
The global Preimplantation Genetic Screening market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Preimplantation Genetic Screening in various end use industries. The expanding demands from the Single Gene Disorders, X-linked Disorders, HLA Typing and Gender Identification, are propelling Preimplantation Genetic Screening market. Next Generation Sequencing (NGS), one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Polymerase Chain Reaction (PCR) segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Preimplantation Genetic Screening market, driven by demand from China, the second largest economy with some signs of stabilising, the Preimplantation Genetic Screening market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Preimplantation Genetic Screening, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Preimplantation Genetic Screening market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Preimplantation Genetic Screening market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Preimplantation Genetic Screening sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Preimplantation Genetic Screening covered in this report include Illumina, Inc (US), Thermo Fisher Scientific Inc (US), Agilent Technologies, Inc (US), PerkinElmer, Inc (US), CooperSurgical, Inc (US) and Beijing Genomics Institute (BGI) (China), etc.
The global Preimplantation Genetic Screening market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Illumina, Inc (US)
Thermo Fisher Scientific Inc (US)
Agilent Technologies, Inc (US)
PerkinElmer, Inc (US)
CooperSurgical, Inc (US)
Beijing Genomics Institute (BGI) (China)
Global Preimplantation Genetic Screening market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Preimplantation Genetic Screening market, Segment by Type:
Next Generation Sequencing (NGS)
Polymerase Chain Reaction (PCR)
Fluorescent In-situ Hybridization (FISH)
Comparative Genomic Hybridization (CGH)
Single Nucleotide Polymorphism (SNP)
Global Preimplantation Genetic Screening market, by Application
Single Gene Disorders
X-linked Disorders
HLA Typing
Gender Identification
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Preimplantation Genetic Screening companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
The global Preimplantation Genetic Screening market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Preimplantation Genetic Screening in various end use industries. The expanding demands from the Single Gene Disorders, X-linked Disorders, HLA Typing and Gender Identification, are propelling Preimplantation Genetic Screening market. Next Generation Sequencing (NGS), one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Polymerase Chain Reaction (PCR) segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Preimplantation Genetic Screening market, driven by demand from China, the second largest economy with some signs of stabilising, the Preimplantation Genetic Screening market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Preimplantation Genetic Screening, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Preimplantation Genetic Screening market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Preimplantation Genetic Screening market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Preimplantation Genetic Screening sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Preimplantation Genetic Screening covered in this report include Illumina, Inc (US), Thermo Fisher Scientific Inc (US), Agilent Technologies, Inc (US), PerkinElmer, Inc (US), CooperSurgical, Inc (US) and Beijing Genomics Institute (BGI) (China), etc.
The global Preimplantation Genetic Screening market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Illumina, Inc (US)
Thermo Fisher Scientific Inc (US)
Agilent Technologies, Inc (US)
PerkinElmer, Inc (US)
CooperSurgical, Inc (US)
Beijing Genomics Institute (BGI) (China)
Global Preimplantation Genetic Screening market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Preimplantation Genetic Screening market, Segment by Type:
Next Generation Sequencing (NGS)
Polymerase Chain Reaction (PCR)
Fluorescent In-situ Hybridization (FISH)
Comparative Genomic Hybridization (CGH)
Single Nucleotide Polymorphism (SNP)
Global Preimplantation Genetic Screening market, by Application
Single Gene Disorders
X-linked Disorders
HLA Typing
Gender Identification
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Preimplantation Genetic Screening companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Preimplantation Genetic Screening
1.1 Preimplantation Genetic Screening Market Overview
1.1.1 Preimplantation Genetic Screening Product Scope
1.1.2 Preimplantation Genetic Screening Market Status and Outlook
1.2 Global Preimplantation Genetic Screening Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Preimplantation Genetic Screening Market Size by Region (2018-2029)
1.4 Global Preimplantation Genetic Screening Historic Market Size by Region (2018-2023)
1.5 Global Preimplantation Genetic Screening Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Preimplantation Genetic Screening Market Size (2018-2029)
1.6.1 North America Preimplantation Genetic Screening Market Size (2018-2029)
1.6.2 Europe Preimplantation Genetic Screening Market Size (2018-2029)
1.6.3 Asia-Pacific Preimplantation Genetic Screening Market Size (2018-2029)
1.6.4 Latin America Preimplantation Genetic Screening Market Size (2018-2029)
1.6.5 Middle East & Africa Preimplantation Genetic Screening Market Size (2018-2029)
2 Preimplantation Genetic Screening Market by Type
2.1 Introduction
2.1.1 Next Generation Sequencing (NGS)
2.1.2 Polymerase Chain Reaction (PCR)
2.1.3 Fluorescent In-situ Hybridization (FISH)
2.1.4 Comparative Genomic Hybridization (CGH)
2.1.5 Single Nucleotide Polymorphism (SNP)
2.2 Global Preimplantation Genetic Screening Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Preimplantation Genetic Screening Historic Market Size by Type (2018-2023)
2.2.2 Global Preimplantation Genetic Screening Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Preimplantation Genetic Screening Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Preimplantation Genetic Screening Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Preimplantation Genetic Screening Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Preimplantation Genetic Screening Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Preimplantation Genetic Screening Revenue Breakdown by Type (2018-2029)
3 Preimplantation Genetic Screening Market Overview by Application
3.1 Introduction
3.1.1 Single Gene Disorders
3.1.2 X-linked Disorders
3.1.3 HLA Typing
3.1.4 Gender Identification
3.2 Global Preimplantation Genetic Screening Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Preimplantation Genetic Screening Historic Market Size by Application (2018-2023)
3.2.2 Global Preimplantation Genetic Screening Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Preimplantation Genetic Screening Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Preimplantation Genetic Screening Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Preimplantation Genetic Screening Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Preimplantation Genetic Screening Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Preimplantation Genetic Screening Revenue Breakdown by Application (2018-2029)
4 Preimplantation Genetic Screening Competition Analysis by Players
4.1 Global Preimplantation Genetic Screening Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Preimplantation Genetic Screening as of 2022)
4.3 Date of Key Players Enter into Preimplantation Genetic Screening Market
4.4 Global Top Players Preimplantation Genetic Screening Headquarters and Area Served
4.5 Key Players Preimplantation Genetic Screening Product Solution and Service
4.6 Competitive Status
4.6.1 Preimplantation Genetic Screening Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Illumina, Inc (US)
5.1.1 Illumina, Inc (US) Profile
5.1.2 Illumina, Inc (US) Main Business
5.1.3 Illumina, Inc (US) Preimplantation Genetic Screening Products, Services and Solutions
5.1.4 Illumina, Inc (US) Preimplantation Genetic Screening Revenue (US$ Million) & (2018-2023)
5.1.5 Illumina, Inc (US) Recent Developments
5.2 Thermo Fisher Scientific Inc (US)
5.2.1 Thermo Fisher Scientific Inc (US) Profile
5.2.2 Thermo Fisher Scientific Inc (US) Main Business
5.2.3 Thermo Fisher Scientific Inc (US) Preimplantation Genetic Screening Products, Services and Solutions
5.2.4 Thermo Fisher Scientific Inc (US) Preimplantation Genetic Screening Revenue (US$ Million) & (2018-2023)
5.2.5 Thermo Fisher Scientific Inc (US) Recent Developments
5.3 Agilent Technologies, Inc (US)
5.3.1 Agilent Technologies, Inc (US) Profile
5.3.2 Agilent Technologies, Inc (US) Main Business
5.3.3 Agilent Technologies, Inc (US) Preimplantation Genetic Screening Products, Services and Solutions
5.3.4 Agilent Technologies, Inc (US) Preimplantation Genetic Screening Revenue (US$ Million) & (2018-2023)
5.3.5 PerkinElmer, Inc (US) Recent Developments
5.4 PerkinElmer, Inc (US)
5.4.1 PerkinElmer, Inc (US) Profile
5.4.2 PerkinElmer, Inc (US) Main Business
5.4.3 PerkinElmer, Inc (US) Preimplantation Genetic Screening Products, Services and Solutions
5.4.4 PerkinElmer, Inc (US) Preimplantation Genetic Screening Revenue (US$ Million) & (2018-2023)
5.4.5 PerkinElmer, Inc (US) Recent Developments
5.5 CooperSurgical, Inc (US)
5.5.1 CooperSurgical, Inc (US) Profile
5.5.2 CooperSurgical, Inc (US) Main Business
5.5.3 CooperSurgical, Inc (US) Preimplantation Genetic Screening Products, Services and Solutions
5.5.4 CooperSurgical, Inc (US) Preimplantation Genetic Screening Revenue (US$ Million) & (2018-2023)
5.5.5 CooperSurgical, Inc (US) Recent Developments
5.6 Beijing Genomics Institute (BGI) (China)
5.6.1 Beijing Genomics Institute (BGI) (China) Profile
5.6.2 Beijing Genomics Institute (BGI) (China) Main Business
5.6.3 Beijing Genomics Institute (BGI) (China) Preimplantation Genetic Screening Products, Services and Solutions
5.6.4 Beijing Genomics Institute (BGI) (China) Preimplantation Genetic Screening Revenue (US$ Million) & (2018-2023)
5.6.5 Beijing Genomics Institute (BGI) (China) Recent Developments
6 North America
6.1 North America Preimplantation Genetic Screening Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Preimplantation Genetic Screening Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Preimplantation Genetic Screening Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Preimplantation Genetic Screening Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Preimplantation Genetic Screening Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Preimplantation Genetic Screening Market Dynamics
11.1 Preimplantation Genetic Screening Industry Trends
11.2 Preimplantation Genetic Screening Market Drivers
11.3 Preimplantation Genetic Screening Market Challenges
11.4 Preimplantation Genetic Screening Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest IT & Electronics Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
